FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marco Chianelli

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Procedures

Isotope Labeling

Concepts & Ideas

Occupations

Nuclear Medicine

Co-author Network

Publications

TOP 3
Maria Gemma Parisella; V Todino; Rudi Dierckx; Marco Chianelli; Calogero D'Alessandria; Renata Mikolajczak; Enrico Papini; Francesco Scopinaro; Alberto Signore
Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
Enrico Papini; Dario Valle; Hossein Gharib; Antonio Bianchini; Marco Chianelli; Anna Crescenzi; Filomena Graziano; Rinaldo Guglielmi; Gharib Hosseim; Irene Misischi; Giancarlo Bizzarri
Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk.
Marco Chianelli; Alberto Signore; Luigi Mansi; Massimo Salvatori
Time for radiobiology in the nuclear medicine community.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marco Chianelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maria Gemma Parisella; V Todino; Rudi Dierckx; Marco Chianelli; Calogero D'Alessandria; Renata Mikolajczak; Enrico Papini; Francesco Scopinaro; Alberto Signore
Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2012;56(1):90-8.
2011: Enrico Papini; Dario Valle; Hossein Gharib; Antonio Bianchini; Marco Chianelli; Anna Crescenzi; Filomena Graziano; Rinaldo Guglielmi; Gharib Hosseim; Irene Misischi; Giancarlo Bizzarri
Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk.
Thyroid : official journal of the American Thyroid Association 2011;21(8):917-20.
2011: Marco Chianelli; Alberto Signore; Luigi Mansi; Massimo Salvatori
Time for radiobiology in the nuclear medicine community.
European journal of nuclear medicine and molecular imaging 2011;38(7):1267-9.
2010: Calogero D'Alessandria; Valentina di Gialleonardo; Marco Chianelli; Stephen J Mather; Erik F J de Vries; Francesco Scopinaro; Rudi A Dierck; Alberto Signore
Synthesis and optimization of the labeling procedure of 99mTc-HYNIC-interleukin-2 for in vivo imaging of activated T lymphocytes.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(5):539-46.
2008: Marco Chianelli; Maria Gemma Parisella; Natalia Visalli; S J Mather; Calogero D'Alessandria; Paolo Pozzilli; Alberto Signore
Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy.
Diabetes/metabolism research and reviews 2008;24(2):115-22.
2006: Gabriela Capriotti; Marco Chianelli; Alberto Signore
Nuclear medicine imaging of diabetic foot infection: results of meta-analysis.
Nuclear medicine communications 2006;27(10):757-64.
2006: Alberto Signore; Marco Chianelli; Calogero D'Alessandria; Alessio Annovazzi
Receptor targeting agents for imaging inflammation/infection: where are we now?
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(3):236-42.
2006: Marco Chianelli; Calogero D'Alessandria; Fabrizio Conti; Roberta Priori; Guido Valesini; Alessio Annovazzi; Alberto Signore
New radiopharmaceuticals for imaging rheumatoid arthritis.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(3):217-25.
2004: Alberto Signore; Alessio Annovazzi; Raffaella Barone; Elena Bonanno; Calogero D'Alessandria; Marco Chianelli; Stephen J Mather; Ugo Bottoni; Chiara Panetta; Daniele Innocenzi; Francesco Scopinaro; Stefano Calvieri
99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1647-52.
2004: Maria Gemma Parisella; Calogero D'Alessandria; Bieke van de Bossche; Marco Chianelli; Giuseppe Ronga; Enrico Papini; Renata Mikolajczak; Claudio Letizia; Giorgio De Toma; Augusto Veneziani; Francesco Scopinaro; Alberto Signore
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):211-7.
2004: Frederica Corsetti; Marco Chianelli; Bart Cornelissen; Christophe Van De Wiele; Calogero D'Alessandria; Guido Slegers; Stephen J Mather; Umberto Di Mario; Sebastiano Filetti; Francesco Scopinaro; Alberto Signore
Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):57-63.
2003: Marco Chianelli; Maria Gemma Parisella; Calogero D'Alessandria; Frederica Corsetti; Francesco Scopinaro; Alberto Signore
The developing role of peptide radiopharmaceuticals in the study of chronic inflammation: new techniques for novel therapeutic options.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(4):256-69.
2003: Alessio Annovazzi; Livia Biancone; Renato Caviglia; Marco Chianelli; Gabriela Capriotti; Stephen J Mather; Renzo Caprilli; Francesco Pallone; Francesco Scopinaro; Alberto Signore
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.
European journal of nuclear medicine and molecular imaging 2003;30(3):374-82.
2003: Alberto Signore; Marco Chianelli; Roberto Bei; W Oyen; Andrea Modesti
Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine.
European journal of nuclear medicine and molecular imaging 2003;30(1):149-56.
2002: Alberto Signore; Alessio Annovazzi; Frederica Corsetti; Gabriela Capriotti; Marco Chianelli; Frederic De Winter; Francesco Scopinaro
Biological imaging for the diagnosis of inflammatory conditions.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2002;16(4):241-59.
2001: Alberto Signore; Alessio Annovazzi; Marco Chianelli; Frederica Corsetti; Christophe Van De Wiele; R N Watherhouse
Peptide radiopharmaceuticals for diagnosis and therapy.
European journal of nuclear medicine 2001;28(10):1555-65.
2000: Alberto Signore; E Procaccini; Alessio Annovazzi; Marco Chianelli; C van der Laken; A Mire-Sluis
The developing role of cytokines for imaging inflammation and infection.
Cytokine 2000;12(10):1445-54.
2000: Alberto Signore; Marco Chianelli; Alessio Annovazzi; Elena Bonanno; Luigi Giusto Spagnoli; Paolo Pozzilli; Francesco Pallone; Livia Biancone
123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(2):242-9.
2000: Alberto Signore; Marco Chianelli; Alessio Annovazzi; M Rossi; Luigi Maiuri; M Greco; Giuseppe Ronga; K E Britton; Antonio Picarelli
Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet.
European journal of nuclear medicine 2000;27(1):18-24.
1999: E Procaccini; Marco Chianelli; P Pantano; Alberto Signore
Imaging of autoimmune diseases.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1999;43(1):100-12.
1999: Giovanni Zuliani; Marcello Arca; Alberto Signore; giovanni bader; S Fazio; Marco Chianelli; S Bellosta; Filomena Campagna; Anna Montali; Mario Maioli; A Pacifico; Giorgio Ricci; Renato Fellin
Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):802-9.
1999: Alberto Signore; Marco Chianelli; Maria Gemma Parisella; Gabriela Capriotti; P Giacalone; G Di Leve; Raffaella Barone
In vivo imaging of insulitis in autoimmune diabetes.
Journal of endocrinological investigation 1999;22(2):151-8.
1998: Raffaella Barone; E Procaccini; Marco Chianelli; Alessio Annovazzi; V Fiore; M Hawa; G Nardi; Giuseppe Ronga; Paolo Pozzilli; Alberto Signore
Prognostic relevance of pancreatic uptake of technetium-99m labelled human polyclonal immunoglobulins in patients with type 1 diabetes.
European journal of nuclear medicine 1998;25(5):503-8.
1997: Marco Chianelli; Alberto Signore; A R Fritzberg; Stephen J Mather
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases.
Nuclear medicine and biology 1997;24(6):579-86.
1997: Marco Chianelli; Stephen J Mather; J Martin-Comin; Alberto Signore
Radiopharmaceuticals for the study of inflammatory processes: a review.
Nuclear medicine communications 1997;18(5):437-55.
1996: Stephen J Mather; Marco Chianelli
Radiolabelled cytokines.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(3):290-300.
1996: Alberto Signore; V Fiore; Marco Chianelli; E Procaccini; R Barone; Giuseppe Ronga; M Negri; Paolo Pozzilli
The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes.
Diabetes research and clinical practice 1996;33(2):83-7.
1996: Alberto Signore; R Barone; E Procaccini; Alessio Annovazzi; Marco Chianelli; Francesco Scopinaro; Giuseppe Ronga; G Multari; W J Looman; Paolo Pozzilli
In vivo measurement of immunoglobulin accumulation in the pancreas of recent onset type 1 diabetic patients.
Clinical and experimental rheumatology 1996;14 Suppl 15():S41-5.
1996: Alberto Signore; Antonio Picarelli; Marco Chianelli; L Biancone; Alessio Annovazzi; Claudio Tiberti; Emanuela Anastasi; G Multari; M Negri; Francesco Pallone; Paolo Pozzilli
I-interleukin-2 scintigraphy: a new approach to assess disease activity in autoimmunity.
Journal of pediatric endocrinology & metabolism : JPEM 1996;9 Suppl 1():139-44.
1995: Alberto Signore; E Procaccini; Marco Chianelli; G Salerno; P Iozzo; Alessio Annovazzi; Frida Leonetti; Guido Tamburrano; Giuseppe Ronga
SPECT imaging with 111In-octreotide for the localization of pancreatic insulinoma.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1995;39(4 Suppl 1):111-2.
1995: Alberto Signore; V Fiore; Marco Chianelli; Giuseppe Ronga; Paolo Pozzilli
Effect of metformin on liver insulin metabolism and regional blood flow.
Diabetes/metabolism reviews 1995;11 Suppl 1():S13-21.
1995: Alberto Signore; E Procaccini; Marco Chianelli; Paolo Pozzilli
Retroviruses and diabetes in animal models: hypotheses for the induction of the disease.
Diabète & métabolisme 1995;21(3):147-55.
1995: Gianfranco Tonnarini; Gianfranco Delle Fave; Marco Chianelli; Paolo Mariani; M Negri
Beta-endorphin in silent duodenal ulcer.
European journal of gastroenterology & hepatology 1995;7(4):357-60.
1994: Alberto Signore; Marco Chianelli; Elisabetta Ferretti; A Toscano; K E Britton; D Andreani; E A Gale; Paolo Pozzilli
New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2.
European journal of endocrinology / European Federation of Endocrine Societies 1994;131(4):431-7.
1993: Marco Chianelli; Alberto Signore; R Hicks; Roberto Testi; M Negri; P C Beverley
A simple method for the evaluation of receptor binding capacity of modified cytokines.
Journal of immunological methods 1993;166(2):177-82.
1992: Alberto Signore; Marco Chianelli; A Toscano; L Monetini; Giuseppe Ronga; C C Nimmon; K E Britton; Paolo Pozzilli; M Negri
A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies.
Nuclear medicine communications 1992;13(10):713-22.
1992: PE Beales; A Williams; J Krug; Alberto Signore; Marco Chianelli; D Andreani; Paolo Pozzilli
Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse.
Diabète & métabolisme 1992;18(1):48-53.
1990: Maurizio Sensi; M R Bruno; L Valente; G P Cioccia; Marco Chianelli; Paolo Pozzilli
Retinol binding protein: a short half life determinant of protein non enzymatic glycation in diabetes.
Diabetes research (Edinburgh, Scotland) 1990;13(4):195-8.
1990: Alberto Signore; Marco Chianelli; Giuseppe Ronga; Paolo Pozzilli; P C Beverley
In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes.
Progress in clinical and biological research 1990;355():229-38.
1989: S Pagani; L Cruciani; Marco Chianelli; E Procaccini; Paolo Pozzilli
Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients.
Diabetes research (Edinburgh, Scotland) 1989;12(4):199-201.